Sanjay de Mel

About Sanjay de Mel

Sanjay de Mel, With an exceptional h-index of 21 and a recent h-index of 19 (since 2020), a distinguished researcher at National University of Singapore, specializes in the field of Haematology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract P21: Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma

Abstract P07: Extracellular Vesicles Secreted from Daratumumab Resistant Cells Promote Resistance and Proliferation of Daratumumab Sensitive cells, possibly Through the …

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma

Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis

Targeting the DNA damage response in hematological malignancies

Spatially-resolved transcriptomics define clinically relevant subsets of macrophages in diffuse large B-cell lymphoma

High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma

Clinical evaluation of a functional combinatorial precision medicine platform to predict combination immunotherapy responses in hematological malignancies

Sanjay de Mel Information

University

Position

Department of Haematology Oncology Cancer Institute Singapore

Citations(all)

1380

Citations(since 2020)

1204

Cited By

533

hIndex(all)

21

hIndex(since 2020)

19

i10Index(all)

34

i10Index(since 2020)

32

Email

University Profile Page

Google Scholar

Sanjay de Mel Skills & Research Interests

Haematology

Top articles of Sanjay de Mel

Abstract P21: Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma

Cancer Research

2024/4/15

Abstract P07: Extracellular Vesicles Secreted from Daratumumab Resistant Cells Promote Resistance and Proliferation of Daratumumab Sensitive cells, possibly Through the …

Cancer Research

2024/4/15

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Nurulhuda Mustafa
Nurulhuda Mustafa

H-Index: 9

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma

Nature Communications

2024/3/8

Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis

2024/3/5

Targeting the DNA damage response in hematological malignancies

2024

Spatially-resolved transcriptomics define clinically relevant subsets of macrophages in diffuse large B-cell lymphoma

medRxiv

2023/3/6

High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma

Journal of Clinical Oncology

2023/12/10

Clinical evaluation of a functional combinatorial precision medicine platform to predict combination immunotherapy responses in hematological malignancies

Cancer Research

2023/4/4

Abstract A125: Clinical evaluation of a functional combinatorial precision medicine platform to predict combination immunotherapy responses in hematological malignancies

Molecular Cancer Therapeutics

2023/12/1

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Daratumumab Bortezomib and Dexamethasone in Transplant Ineligible Newly Diagnosed Elderly Myeloma Patients-a Trial By Asian Myeloma Network

Blood

2023/11/28

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Lawrence Ng
Lawrence Ng

H-Index: 3

Extracellular Vesicles Secreted from Daratumumab Resistant Cells Promote Resistance and Proliferation of Daratumumab Sensitive Cells, Possibly through the Transfer of miRNA Cargo

Blood

2023/11/28

Nurulhuda Mustafa
Nurulhuda Mustafa

H-Index: 9

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Single Cell Profiling Unravels Plasma Cell Gene Expression Signatures Predictive of Response to Daratumumab Based Therapy, and Prognosis in Multiple Myeloma

Blood

2023/11/28

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Development of a Novel Artificial Intelligence Tool to Measure Psoas Volumes in Patients with Diffuse Large B Cell Lymphoma

Blood

2023/11/28

Sanjay De Mel
Sanjay De Mel

H-Index: 13

A Phase 2 Study of Daratumumab in Combination with Thalidomide and Dexamethasone in Relapsed and/or Refractory Myeloma: A Report from the Asian Myeloma Network

Blood

2023/11/28

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Clinical utility of PET/MRI in multiple myeloma

ANNALS ACADEMY OF MEDICINE SINGAPORE

2023/11/1

Sanjay De Mel
Sanjay De Mel

H-Index: 13

AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management

ANNALS ACADEMY OF MEDICINE SINGAPORE

2023/11/1

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Effectiveness of resilience interventions among cancer patients–A systematic review, meta-analyses, and meta-regression of randomized controlled trials

2023/10/14

Wei How Darryl Ang
Wei How Darryl Ang

H-Index: 2

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Venous thromboembolism in an Asian COVID-19 cohort across 3 infection waves—a retrospective observational study

Research and Practice in Thrombosis and Haemostasis

2023/10/1

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Eng Soo Yap
Eng Soo Yap

H-Index: 8

Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma

2023/10

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study

Leukemia & Lymphoma

2023/9/19

Sanjay De Mel
Sanjay De Mel

H-Index: 13

Tiffany Tang
Tiffany Tang

H-Index: 5

See List of Professors in Sanjay de Mel University(National University of Singapore)